A Contract Research Organization (CRO) is a service provider, which offers end-to-end solutions in conducting clinical trials for biopharmaceutical and medical device companies. The core services offered by CROs to biopharmaceutical companies include initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services. Many pharmaceutical companies often outsource their R&D activities to CROs and is expected that these companies will increase their outsourcing activities for drug development process to CROs in future.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Description

Where is the largest and fastest growing market for CRO? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CRO global market report from the Business Research Company answers all these questions and many more.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. The section also gives the production data of CRO market for the historic period. Drivers and restraints cover the external factors supporting and controlling the growth of the market.

Porters five force model covers the threat of new entrants, threat of substitutes, bargaining power of buyers, bargaining power of suppliers and industry competition for the CRO market.

Market segmentation by service breaks down the market into sub markets. By service type, the market is segmented into drug discovery, preclinical studies, phase 1, phase 2, phase 3 ,phase 4, others . Market segmentation is also done by type of therapeutic area, which includes oncology, cardiovascular disease, CNS disorder, infectious disease, metabolic disease and others. The historic and forecast growth rates for these segments are also covered in this report.

The regional and country breakdown section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets.

The competitive landscape section gives a description of the competitive nature of the market, market shares, and a description of the leading companies in terms of their offerings, growth strategy and financial performance.

The customer information section covers major surveys conducted on the global CRO market and their implications.

The report also covers key mergers and acquisitions in the CRO market. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.